Large-scale testing (Phase 3)Looking for participantsNCT05879276
What this trial is testing
Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Who this might be right for
Cardiogenic Shock
Central Hospital, Nancy, France 164